Cargando…

Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: Extremely low gestational age neonates are at risk of disorders of fluid balance (FB), defined as change in fluid weight over a specific period. Few data exist on the association between FB and respiratory outcomes in this population. OBJECTIVE: To describe FB patterns and evaluate the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Starr, Michelle C., Griffin, Russell, Gist, Katja M., Segar, Jeffrey L., Raina, Rupesh, Guillet, Ronnie, Nesargi, Saudamini, Menon, Shina, Anderson, Nekayla, Askenazi, David J., Selewski, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856967/
https://www.ncbi.nlm.nih.gov/pubmed/36580332
http://dx.doi.org/10.1001/jamanetworkopen.2022.48826
_version_ 1784873758905860096
author Starr, Michelle C.
Griffin, Russell
Gist, Katja M.
Segar, Jeffrey L.
Raina, Rupesh
Guillet, Ronnie
Nesargi, Saudamini
Menon, Shina
Anderson, Nekayla
Askenazi, David J.
Selewski, David T.
author_facet Starr, Michelle C.
Griffin, Russell
Gist, Katja M.
Segar, Jeffrey L.
Raina, Rupesh
Guillet, Ronnie
Nesargi, Saudamini
Menon, Shina
Anderson, Nekayla
Askenazi, David J.
Selewski, David T.
author_sort Starr, Michelle C.
collection PubMed
description IMPORTANCE: Extremely low gestational age neonates are at risk of disorders of fluid balance (FB), defined as change in fluid weight over a specific period. Few data exist on the association between FB and respiratory outcomes in this population. OBJECTIVE: To describe FB patterns and evaluate the association of FB with respiratory outcomes in a cohort of extremely low gestational age neonates. DESIGN, SETTING, AND PARTICIPANTS: This study is a secondary analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT), a phase 3 placebo-controlled randomized clinical trial of erythropoietin in extremely premature neonates conducted in 30 neonatal intensive care units in the US from December 1, 2013, to September 31, 2016. This analysis included 874 extremely premature neonates born at 24 to 27 weeks’ gestation who were enrolled in the PENUT study. Secondary analysis was performed in November 2021. EXPOSURES: Primary exposure was peak FB during the first 14 postnatal days. The FB was calculated as percent change in weight from birth weight (BW) as a surrogate for FB. MAIN OUTCOMES AND MEASURES: The primary outcome was mechanical ventilation on postnatal day 14. The secondary outcome was a composite of severe bronchopulmonary dysplasia (BPD) or death. RESULTS: A total of 874 neonates (449 [51.4%] male; mean [SD] BW, 801 [188] g; 187 [21.4%] Hispanic, 676 [77.3%] non-Hispanic, and 11 [1.3%] of unknown ethnicity; 226 [25.9%] Black, 569 [65.1%] White, 51 [5.8%] of other race, and 28 [3.2%] of unknown race) were included in this analysis. Of these 874 neonates, 458 (52.4%) received mechanical ventilation on postnatal day 14, and 291 (33.3%) had severe BPD or had died. Median peak positive FB was 11% (IQR, 4%-20%), occurring on postnatal day 13 (IQR, 9-14). A total of 93 (10.6%) never decreased below their BW. Neonates requiring mechanical ventilation at postnatal day 14 had a higher peak FB compared with those who did not require mechanical ventilation (15% above BW vs 8% above BW, P < .001). On postnatal day 3, neonates requiring mechanical ventilation were more likely to have a higher FB (5% below BW vs 8% below BW, P < .001). The median time to return to BW was shorter in neonates who received mechanical ventilation (7 vs 8 days, P < .001) and those with severe BPD (7 vs 8 days, P < .001). After adjusting for confounding variables, for every 10% increase in peak FB during the first 14 postnatal days, there was 103% increased odds of receiving mechanical ventilation at postnatal day 14 (adjusted odds ratio, 2.03; 95% CI, 1.64-2.51). CONCLUSIONS AND RELEVANCE: In this secondary analysis of a randomized clinical trial, peak FB was associated with mechanical ventilation on postnatal day 14 and severe BPD or death. Fluid balance in the first 3 postnatal days and time to return to BW may be potential targets to help guide management and improve respiratory outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01378273
format Online
Article
Text
id pubmed-9856967
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-98569672023-02-03 Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial Starr, Michelle C. Griffin, Russell Gist, Katja M. Segar, Jeffrey L. Raina, Rupesh Guillet, Ronnie Nesargi, Saudamini Menon, Shina Anderson, Nekayla Askenazi, David J. Selewski, David T. JAMA Netw Open Original Investigation IMPORTANCE: Extremely low gestational age neonates are at risk of disorders of fluid balance (FB), defined as change in fluid weight over a specific period. Few data exist on the association between FB and respiratory outcomes in this population. OBJECTIVE: To describe FB patterns and evaluate the association of FB with respiratory outcomes in a cohort of extremely low gestational age neonates. DESIGN, SETTING, AND PARTICIPANTS: This study is a secondary analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT), a phase 3 placebo-controlled randomized clinical trial of erythropoietin in extremely premature neonates conducted in 30 neonatal intensive care units in the US from December 1, 2013, to September 31, 2016. This analysis included 874 extremely premature neonates born at 24 to 27 weeks’ gestation who were enrolled in the PENUT study. Secondary analysis was performed in November 2021. EXPOSURES: Primary exposure was peak FB during the first 14 postnatal days. The FB was calculated as percent change in weight from birth weight (BW) as a surrogate for FB. MAIN OUTCOMES AND MEASURES: The primary outcome was mechanical ventilation on postnatal day 14. The secondary outcome was a composite of severe bronchopulmonary dysplasia (BPD) or death. RESULTS: A total of 874 neonates (449 [51.4%] male; mean [SD] BW, 801 [188] g; 187 [21.4%] Hispanic, 676 [77.3%] non-Hispanic, and 11 [1.3%] of unknown ethnicity; 226 [25.9%] Black, 569 [65.1%] White, 51 [5.8%] of other race, and 28 [3.2%] of unknown race) were included in this analysis. Of these 874 neonates, 458 (52.4%) received mechanical ventilation on postnatal day 14, and 291 (33.3%) had severe BPD or had died. Median peak positive FB was 11% (IQR, 4%-20%), occurring on postnatal day 13 (IQR, 9-14). A total of 93 (10.6%) never decreased below their BW. Neonates requiring mechanical ventilation at postnatal day 14 had a higher peak FB compared with those who did not require mechanical ventilation (15% above BW vs 8% above BW, P < .001). On postnatal day 3, neonates requiring mechanical ventilation were more likely to have a higher FB (5% below BW vs 8% below BW, P < .001). The median time to return to BW was shorter in neonates who received mechanical ventilation (7 vs 8 days, P < .001) and those with severe BPD (7 vs 8 days, P < .001). After adjusting for confounding variables, for every 10% increase in peak FB during the first 14 postnatal days, there was 103% increased odds of receiving mechanical ventilation at postnatal day 14 (adjusted odds ratio, 2.03; 95% CI, 1.64-2.51). CONCLUSIONS AND RELEVANCE: In this secondary analysis of a randomized clinical trial, peak FB was associated with mechanical ventilation on postnatal day 14 and severe BPD or death. Fluid balance in the first 3 postnatal days and time to return to BW may be potential targets to help guide management and improve respiratory outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01378273 American Medical Association 2022-12-29 /pmc/articles/PMC9856967/ /pubmed/36580332 http://dx.doi.org/10.1001/jamanetworkopen.2022.48826 Text en Copyright 2022 Starr MC et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Starr, Michelle C.
Griffin, Russell
Gist, Katja M.
Segar, Jeffrey L.
Raina, Rupesh
Guillet, Ronnie
Nesargi, Saudamini
Menon, Shina
Anderson, Nekayla
Askenazi, David J.
Selewski, David T.
Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial
title Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial
title_full Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial
title_fullStr Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial
title_full_unstemmed Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial
title_short Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial
title_sort association of fluid balance with short- and long-term respiratory outcomes in extremely premature neonates: a secondary analysis of a randomized clinical trial
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856967/
https://www.ncbi.nlm.nih.gov/pubmed/36580332
http://dx.doi.org/10.1001/jamanetworkopen.2022.48826
work_keys_str_mv AT starrmichellec associationoffluidbalancewithshortandlongtermrespiratoryoutcomesinextremelyprematureneonatesasecondaryanalysisofarandomizedclinicaltrial
AT griffinrussell associationoffluidbalancewithshortandlongtermrespiratoryoutcomesinextremelyprematureneonatesasecondaryanalysisofarandomizedclinicaltrial
AT gistkatjam associationoffluidbalancewithshortandlongtermrespiratoryoutcomesinextremelyprematureneonatesasecondaryanalysisofarandomizedclinicaltrial
AT segarjeffreyl associationoffluidbalancewithshortandlongtermrespiratoryoutcomesinextremelyprematureneonatesasecondaryanalysisofarandomizedclinicaltrial
AT rainarupesh associationoffluidbalancewithshortandlongtermrespiratoryoutcomesinextremelyprematureneonatesasecondaryanalysisofarandomizedclinicaltrial
AT guilletronnie associationoffluidbalancewithshortandlongtermrespiratoryoutcomesinextremelyprematureneonatesasecondaryanalysisofarandomizedclinicaltrial
AT nesargisaudamini associationoffluidbalancewithshortandlongtermrespiratoryoutcomesinextremelyprematureneonatesasecondaryanalysisofarandomizedclinicaltrial
AT menonshina associationoffluidbalancewithshortandlongtermrespiratoryoutcomesinextremelyprematureneonatesasecondaryanalysisofarandomizedclinicaltrial
AT andersonnekayla associationoffluidbalancewithshortandlongtermrespiratoryoutcomesinextremelyprematureneonatesasecondaryanalysisofarandomizedclinicaltrial
AT askenazidavidj associationoffluidbalancewithshortandlongtermrespiratoryoutcomesinextremelyprematureneonatesasecondaryanalysisofarandomizedclinicaltrial
AT selewskidavidt associationoffluidbalancewithshortandlongtermrespiratoryoutcomesinextremelyprematureneonatesasecondaryanalysisofarandomizedclinicaltrial